BeneMeat hosted representatives of the Czech Meat Processors Association at its pilot production site in June, according to vegconomist. The tour and subsequent talks covered cell-based production, possible uses and the European Union’s regulatory treatment of cultivated products.
The meeting ended with an agreement in principle to maintain professional discussion, rather than an association endorsement of the technology, vegconomist reported. Association executive director Radek Slanec called for assessments grounded in verified information, transparency and mutual respect. BeneMeat CEO Roman Kříž separately presented cultivated cells as an additional tool for conventional manufacturers.
BeneMeat supplies manufacturers with cell lines, growth media and processing systems instead of selling a consumer brand, according to vegconomist. Company representative Marek Širl said BeneMeat uses “cultivated meat” when explaining the category publicly, while its product wording identifies cultivated cells and their source. Širl said that packaging approach complies with existing legal and regulatory requirements.
Terminology remains unresolved. Vegconomist linked the discussion to stalled European Union negotiations over names for plant-based alternatives and legislative activity in the United States. Kříž also said BeneMeat had rejected public development funding while arguing that support programs should be available to manufacturers implementing the technology.
CONCLUSION The visit gave BeneMeat a direct forum to frame cultivated-cell systems as inputs for established meat businesses, but vegconomist reported no formal backing from the processors’ association. Labeling rules, regulatory treatment and possible adoption support remain the central open issues identified in the discussions.